Intellia Therapeutics Inc. (NTLA) Dipped -7.72% or -1.07 To Price $12.79 On Thursday


Intellia Therapeutics Inc. (NTLA) dipped -7.72% or -1.07 to $12.79. It is around 621233 shares traded, which is 98.5% compare to the average total volume 630668. The market cap of NTLA is $555.33 million. The year to date change is -6.55%. The 52 week price range is from $11.03 to $35.99. Price of NTLA have changed -1.98% during last week. It have changed -5.71% over last month, -24.88% over last 3 months, -49.29% over last 6 months and -42.32% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NTLA is 14.82. It is 15.87% above current price. The 200-day Moving Averages for NTLA is 22.94. It is 79.36% above current price. The 52-week High is 35.99. It is 181.39% from the current price. The 52-week Low is 11.03. It is -13.76% from current price.

There are some statistics of NTLA. It is has market cap $555.33 million. The share outstanding is 43.42 million. The average volume is 630668. The percent of top 15 Institution holding is 100.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NTLA is -41.27%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NTLA is -31.78%.


Tags:

Share this post